Earnings Outlook For Avadel Pharmaceuticals

Avadel Pharmaceuticals AVDL is gearing up to announce its quarterly earnings on Wednesday, 2025-05-07. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Avadel Pharmaceuticals will report an earnings per share (EPS) of $-0.06.

Avadel Pharmaceuticals bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company missed EPS by $0.01, which was followed by a 1.19% increase in the share price the next day.

Here's a look at Avadel Pharmaceuticals's past performance and the resulting price change:

Market Performance of Avadel Pharmaceuticals's Stock

Shares of Avadel Pharmaceuticals were trading at $9.04 as of May 05. Over the last 52-week period, shares are down 44.06%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all earnings releases for Avadel Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.